Evidence map›Paper›PMID 39713044›Full record

ReviewFrontiers in allergy2024

Milk ladder: Who? When? How? Where? with the lowest risk of reaction.

Betul Buyuktiryaki, Ozge Soyer, Gulbin Bingol, Ceren Can, Hikmet Tekin Nacaroglu, Aysen Bingol, Ebru Arik Yilmaz, Metin Aydogan, Cansin Sackesen

Erratum issuedAbstract readReview
In one paragraph

Review in Frontiers in allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Betul BuyuktiryakiDivision of Pediatric Allergy, Koc University School of Medicine, Istanbul, Türkiye.
Ozge SoyerDivision of Pediatric Allergy, Hacettepe University School of Medicine, Ankara, Türkiye.
Gulbin BingolDivision of Pediatric Allergy, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Türkiye.
Ceren CanDivision of Pediatric Allergy, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University, Istanbul, Türkiye.
Hikmet Tekin NacarogluDivision of Pediatric Allergy, Medipol University School of Medicine, Istanbul, Türkiye.
Aysen BingolDivision of Pediatric Allergy and Immunology, Akdeniz University School of Medicine, Antalya, Türkiye.
Ebru Arik YilmazDivision of Pediatric Allergy and Immunology, Pamukkale University School of Medicine, Denizli, Türkiye.
Metin AydoganDivision of Pediatric Allergy and Immunology, Kocaeli University School of Medicine, Kocaeli, Türkiye.
Cansin SackesenDivision of Pediatric Allergy, Koc University School of Medicine, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The milk ladder (ML) approach, which is the gradual reintroduction of the milk allergen from the least allergenic forms to the most allergenic forms into the diet of the patients, has been utilized mostly in non-IgE-mediated but in some countries also in IgE-mediated-CMPA due to its possible benefits which include nutrition, quality of life and tolerance induction. Despite increasing interest, so far, there is no guideline on ML; thus, the use of this approach shows discrepancies among healthcare professionals as many factors such as dietary habits, patient history, test results, workload, and facilities of the hospitals, the anxiety of the parents/patients may affect the decision on how, when, where and whom to use ML. Here, we reviewed current data on implementing the ML, suggested a 4-step ML including receipts and amounts, and shared our experience on optimal patient selection, appropriate time and steps for initiating ML, and time intervals between the steps targeting the lowest risk of reaction. We also added the newly developed twice-baked biscotti cake to the ML. We presented the analyses of this product, showing its low allergenicity compared to conventional cake, which provides a safer introduction of milk into the diet.

Indexed as

baked milkcow's milk protein allergyfood allergyfood ladderimmunotherapynutritiontolerance inductiontreatment

Identifiers

PMID39713044
PMCPMC11659236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.